From taboo to billion-dollar bet: How psychedelics are entering mainstream medicine

Researchers examined the acute effects of several classic psychedelics and found common changes in functional connectivity between some large-scale brain networks. And these substances become serious candidates for Big Pharma, and they have started pouring money in these drugs, writes Vanita Srivastava.